LabConnect And Bostwick Scientific Launch Centralized Anatomic Pathology Testing Service

Seattle, WA - Central laboratory services provider LabConnect, announced recently that it has signed Bostwick Scientific, the clinical trials division of Bostwick Laboratories, the world's largest provider of centralized anatomic pathology testing services for clinical trials, as an exclusive provider.

The combination of Bostwick Scientific and LabConnect provide clinical trial sponsors with one source for key opinion leaders in anatomic pathology and central laboratory experts and combine the country's fastest growing anatomic pathology lab and central lab. Bostwick Laboratories was formed in 1999 by David G. Bostwick, MD, MBA an internationally renowned expert in urologic pathology. Bostwick Laboratories operates six facilities in the U.S. and Europe and provides histological and cytological diagnosis in human pathology with special expertise in urogenital, gastrointestinal, gynecological, dermatologic and hematologic pathology. Bostwick Scientific has processed more than 35,000 clinical trial cases to date.

"We're in the early stages of the evolution of anatomic pathology testing in clinical trials," noted Eric Hayashi, LabConnect president and chief executive officer. "Sponsors are increasingly realizing the benefits of the centralization of their anatomic pathology testing needs just as they have realized similar benefits in centralizing routine and specialized clinical pathology."

SOURCE: LabConnect, LLC